Status:
NOT_YET_RECRUITING
Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital
Lead Sponsor:
Assiut University
Conditions:
Erythropoietin Resistant Anemia (EPO Resistant Anemia)
Eligibility:
All Genders
18+ years
Brief Summary
* The prevalence of erthropoietin stimulating agents hyporesponsiveness in hemodialysis patients in Assiut university hospital * Assessment of cardiovascular diseases risk in patients with erythropoie...
Detailed Description
Anemia is common in patients with chronic kidney disease. The routine use of erthropoietin in anemia control has reduced morbidity and mortality rates in patients with chronic kidney disease. Despite ...
Eligibility Criteria
Inclusion
- age more than 18
- End stage renal disease patients undergoing regular hemodialysis in Assiut University Hospital - Hemodialysis unit for duration at least 3 months
Exclusion
- acute infectious disease within one month
- active liver disease or cancer
- recent blood transfusion or surgical intervention
- active bleeding or hemorrhage
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06053866
Start Date
February 1 2024
End Date
March 1 2025
Last Update
January 31 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.